News | November 04, 2010

Radiation Oncology Tools Simplify Treatment Planning

November 4, 2010 – Several new radiation oncology tools were on display at the American Society for Therapeutic Radiology and Oncology (ASTRO) meeting in San Diego, Calif. The tools, by Philips, include 4-D imaging, a toolkit to evaluate organ motion and technology to help clinicians view critical structures near the sites of dense metal objects.

Also, the company displayed a tool that allows clinicians to “mark” an area and then initiate treatment via one workstation.

The Gemini TF Big Bore PET/CT (positron emission tomography/computed tomography) enhances the accuracy of treatment planning, while meeting the performance and connectivity requirements of radiation oncology.

“Physicians have long known that adding functional PET imaging to anatomical CT imaging would improve the ability to delineate tumors,” said Steven Braff, M.D., chair, radiology department, Fletcher Allen Health Care, Burlington, Vt. “However, previous systems had a narrow bore size and offered poor positional accuracy. We often find ourselves using the 85 centimeter opening of the Gemini system to its full potential. The large bore is ideal when treating patients who need to be in extended positions and helps us provide the best care possible. The spacious opening is also very well-suited for patients with a high BMI, such as many of the cardiology patients we see.”

Radiation therapy planning is centralized with the Pinnacle SmartEnterprise, which provides remote access to complex therapy plans to treat patients across multiple locations. The Pinnacle SmartArc offers a planning module for volumetric modulated arc therapy (VMAT) and an intensity modulated radiation therapy (IMRT) modality. It is designed to significantly reduce treatment time compared with traditional IMRT.

The Swedish Cancer Institute (SCI) is currently using SmartArc in the treatment of a wide variety of cancers. Clinicians have found it to be useful for all treatment sites that benefit from IMRT.

“Like other clinicians, I want to deliver the highest possible dose of radiation to the tumor and spare the most normal tissue,” said Vivek Mehta, M.D., director of the Center for Advanced Targeted Radiotherapies and a radiation oncologist at the SCI. “It makes sense to me that we would use SmartArc VMAT in every patient that we would consider for IMRT. We tested this hypothesis on 50 consecutive patients and discovered that in 96 percent of the cases the VMAT plan was preferred over the conventional IMRT plan.”

For more information: www.philips.com

Related Content

First Hospitals Achieve Inter-System Connectivity Across Accuray Radiation Therapy Platforms
News | Radiation Therapy | January 19, 2018
Accuray Inc. announced recently that the Heidelberg University Hospital in Heidelberg, Germany, and Oscar Lambret...
RayStation Selected for New Carbon Ion Therapy Center in Japan
News | Treatment Planning | January 18, 2018
January 18, 2018 – RayStation has been chosen as the treatment planning system for a new carbon-ion therapy facility
Raysearch Receives First Order for the Raycare Oncology Information System
News | Oncology Information Management Systems (OIMS) | January 18, 2018
January 18, 2018 – Anderson Regional Cancer Center (ARCC) in Meridian, Mississippi, has placed the first order for...
Mevion Receives 510(k) Clearance for Hyperscan Pencil Beam Scanning Proton Therapy
Technology | Proton Therapy | January 04, 2018
Mevion Medical Systems has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the Mevion S250i...
Study Compares Radiosurgery and Whole-Brain Radiation in Lung Cancer Patients With Multiple Brain Metastases
News | Radiation Therapy | January 03, 2018
Although targeted therapies have produced dramatic advances in the ability to control some types of advanced lung...
MEDraysintell Downgrades Proton Therapy Market Projection for 2030
News | Proton Therapy | January 02, 2018
MEDraysintell recently downgraded its projection for proton therapy rooms expected to be operational in 2030 from 1,200...
California US Oncology Network Centers Adopt Xoft Electronic Brachytherapy System for Early-Stage Non-Melanoma Skin Cancer
News | Brachytherapy Systems | January 02, 2018
iCAD Inc. announced that its Xoft Axxent Electronic Brachytherapy (eBx) System is now available at two California-based...
Blue Phantom System Used for Acceptance of First European Varian Halcyon Machine
News | Radiation Therapy | January 02, 2018
IBA (Ion Beam Applications S.A.) announced in November the acceptance and beam model validation of the first Varian...
Study Finds Link Between Breast Cancer Treatments and Cellular Aging Markers
News | Women's Health | January 02, 2018
January 2, 2018 — A new study found women who had received chemotherapy and/or...
ACR Appropriateness Criteria Adds and Revises Topics for December 2017
News | Clinical Decision Support | December 29, 2017
December 29, 2017 — Radiologists can enhance the quality and effectiveness of care with the newest release of the ACR
Overlay Init